Storia in 3 fonti

A Spanish biotech banks $87M to make differentiated ADCs

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

Raccontata da

biopharmadive.com

lavanguardia.com

endpoints.news

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo3 mesi fa

A Spanish biotech banks $87M to make differentiated ADCs

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

originale

endpoints.news3 mesi fa

ADC biotech Ona Therapeutics secures $86.6M in Series B raise

Barcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic.

Leggi questa versione → originale

Timeline cronologica

giovedì 4 giugno 2026·biopharmadive.com
A Spanish biotech banks $87M to make differentiated ADCs
Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.
giovedì 4 giugno 2026·lavanguardia.com
Ona Therapeutics consigue 74 millones para avanzar en sus fármacos contra el cáncer
La compañía destinará buena parte de los recursos a los ensayos clínicos de su molécula estrella

A Spanish biotech banks $87M to make differentiated ADCs

ADC biotech Ona Therapeutics secures $86.6M in Series B raise

Timeline cronologica

A Spanish biotech banks $87M to make differentiated ADCs

Ona Therapeutics consigue 74 millones para avanzar en sus fármacos contra el cáncer

Ona Therapeutics consigue 74 millones para avanzar en sus fármacos contra el cáncer

ADC biotech Ona Therapeutics secures $86.6M in Series B raise